These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22900918)
1. Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. Chappell NP; Teng PN; Hood BL; Wang G; Darcy KM; Hamilton CA; Maxwell GL; Conrads TP J Proteome Res; 2012 Sep; 11(9):4605-14. PubMed ID: 22900918 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines. Dai Z; Yin J; He H; Li W; Hou C; Qian X; Mao N; Pan L Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754 [TBL] [Abstract][Full Text] [Related]
3. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways]. Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551 [TBL] [Abstract][Full Text] [Related]
5. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer. Aggarwal S; He T; Fitzhugh W; Rosenthal K; Feild B; Heidbrink J; Mesmer D; Ruben SM; Moore PA Gynecol Oncol; 2009 Dec; 115(3):430-7. PubMed ID: 19800108 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. Henkels KM; Turchi JJ Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248 [TBL] [Abstract][Full Text] [Related]
7. Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells. Yang X; Wang J; Zhou Y; Wang Y; Wang S; Zhang W Cancer Lett; 2012 Aug; 321(2):137-43. PubMed ID: 22281241 [TBL] [Abstract][Full Text] [Related]
8. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. RosanĂ² L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
9. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones]. Yan XD; Pan LY Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965 [TBL] [Abstract][Full Text] [Related]
10. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121 [TBL] [Abstract][Full Text] [Related]
11. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines. Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764 [TBL] [Abstract][Full Text] [Related]
12. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
13. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer. Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822 [TBL] [Abstract][Full Text] [Related]
14. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines]. Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691 [TBL] [Abstract][Full Text] [Related]
15. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1. Li F; Meng L; Zhou J; Xing H; Wang S; Xu G; Zhu H; Wang B; Chen G; Lu YP; Ma D Biochem Biophys Res Commun; 2005 Oct; 335(4):1070-7. PubMed ID: 16105650 [TBL] [Abstract][Full Text] [Related]
16. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells. Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165 [TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10. Le Moguen K; Lincet H; Deslandes E; Hubert-Roux M; Lange C; Poulain L; Gauduchon P; Baudin B Proteomics; 2006 Oct; 6(19):5183-92. PubMed ID: 16941573 [TBL] [Abstract][Full Text] [Related]
18. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Yang X; Fraser M; Moll UM; Basak A; Tsang BK Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663 [TBL] [Abstract][Full Text] [Related]
19. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. Yan XD; Pan LY; Yuan Y; Lang JH; Mao N J Proteome Res; 2007 Feb; 6(2):772-80. PubMed ID: 17269733 [TBL] [Abstract][Full Text] [Related]
20. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]